Featured insights and articles

When nearly 80% of a clinical data standards library converts automatically from one programming language to another—compressing months of work into days—the question isn't whether AI can automate clinical trial programming [1]. It's whether the remaining 20% matters enough to stall adoption, and whether sponsors will pay for the risks buried in that last mile.

Here are three proven pivots to flip your biometrics operation from reactive chaos to proactive command center.

Every biometrics leader knows the pain of juggling growing trial complexity with limited internal headcount, overworked staff, and inconsistent CRO performance.

Team composition can make or break any project.

Discussing how FDA budget cuts might effect drug development

At Wu Consulting, supporting a client in the process of obtaining FDA approval is one of the most rewarding services we offer.